Literature DB >> 28548298

Total cerebral small vessel disease score and cognitive performance in community-dwelling older adults. Results from the Atahualpa Project.

Victor J Del Brutto1, Jorge G Ortiz2, Oscar H Del Brutto3, Robertino M Mera4, Mauricio Zambrano5, José Biller2.   

Abstract

OBJECTIVE: Cerebral small vessel disease (SVD) is inversely associated with cognitive performance. However, whether the total SVD score is a better predictor of poor cognitive performance than individual signatures of SVD is inconclusive. We aimed to estimate the combined and independent predictive power of these MRI findings.
METHODS: Atahualpa residents aged ≥60 years underwent brain MRI. Cognitive performance was measured by the Montreal Cognitive Assessment (MoCA). The presence of moderate-to-severe white matter hyperintensities, deep cerebral microbleeds, lacunar infarcts, and >10 enlarged perivascular spaces was added for estimating the total SVD score ranging from 0 to 4 points. Montreal Cognitive Assessment predictive models were fitted to assess how well the total SVD score or each of its components predicts cognitive performance.
RESULTS: Of 351 eligible candidates, 331 (94%) were included. The total SVD score was 0 points in 202 individuals (61%), 1 point in 67 (20%), 2 points in 40 (12%), 3 points in 15 (5%), and 4 points in seven (2%). A generalized lineal model showed an inverse relationship between the total SVD score and the MoCA (p = 0.015). The proportion of variance in the MoCA score explained by the SVD score was 32.8% (R2  = 0.328). This predictive power was similar for white matter hyperintensities (R2  = 0.306), microbleeds (R2  = 0.313), lacunar infarcts (R2  = 0.323), and perivascular spaces (R2  = 0.313).
CONCLUSIONS: This study shows a significant association between the SVD score and worse cognitive performance. The SVD score is a predictor of poor cognitive performance. This predictive power is not better than that of isolated neuroimaging signatures of SVD.
Copyright © 2017 John Wiley & Sons, Ltd. Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cerebral microbleeds; enlarged perivascular spaces; lacunar infarctions; population-based study; small vessel disease score; white matter hyperintensities

Mesh:

Year:  2017        PMID: 28548298     DOI: 10.1002/gps.4747

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  17 in total

1.  Total cerebral small vessel disease score and all-cause mortality in older adults of Amerindian ancestry: The Atahualpa Project.

Authors:  Victor J Del Brutto; Robertino Mera; Bettsy Y Recalde; Denisse A Rumbea; Aldo F Costa; Oscar H Del Brutto
Journal:  Eur Stroke J       Date:  2021-11-10

Review 2.  Imaging Endophenotypes of Stroke as a Target for Genetic Studies.

Authors:  Xueqiu Jian; Myriam Fornage
Journal:  Stroke       Date:  2018-05-14       Impact factor: 7.914

3.  Effect of small-vessel disease on cognitive trajectory after atrial fibrillation-related ischaemic stroke or  TIA.

Authors:  Gargi Banerjee; Edgar Chan; Gareth Ambler; Duncan Wilson; Lisa Cipolotti; Clare Shakeshaft; Hannah Cohen; Tarek Yousry; Gregory Y H Lip; Keith W Muir; Martin M Brown; Hans Rolf Jäger; David J Werring
Journal:  J Neurol       Date:  2019-03-07       Impact factor: 4.849

4.  Predicting Dementia in Cerebral Small Vessel Disease Using an Automatic Diffusion Tensor Image Segmentation Technique.

Authors:  Owen A Williams; Eva A Zeestraten; Philip Benjamin; Christian Lambert; Andrew J Lawrence; Andrew D Mackinnon; Robin G Morris; Hugh S Markus; Thomas R Barrick; Rebecca A Charlton
Journal:  Stroke       Date:  2019-09-12       Impact factor: 7.914

5.  Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease.

Authors:  Jing Du; Yao Wang; Nan Zhi; Jieli Geng; Wenwei Cao; Ling Yu; Jianhua Mi; Yan Zhou; Qun Xu; Wei Wen; Perminder Sachdev
Journal:  Neuroimage Clin       Date:  2019-02-05       Impact factor: 4.881

6.  Tissue Plasminogen Activator and MRI Signs of Cerebral Small Vessel Disease.

Authors:  Larisa A Dobrynina; Alla A Shabalina; Maryam R Zabitova; Elena I Kremneva; Zukhra Sh Gadzhieva; Marina V Krotenkova; Elena V Gnedovskaya; Alexander B Berdalin; Lyudmila A Kalashnikova
Journal:  Brain Sci       Date:  2019-10-05

7.  Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients.

Authors:  Jianping Liu; Weihua Zhao; Qinghong Gui; Ying Zhang; Zaiyu Guo; Wei Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-25       Impact factor: 2.570

Review 8.  Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management.

Authors:  Maria Clara Zanon Zotin; Lukas Sveikata; Anand Viswanathan; Pinar Yilmaz
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 6.283

9.  Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort.

Authors:  Oscar H Del Brutto; Shasha Wu; Robertino M Mera; Aldo F Costa; Bettsy Y Recalde; Naoum P Issa
Journal:  Eur J Neurol       Date:  2021-03-01       Impact factor: 6.288

10.  MRI Lesion Load of Cerebral Small Vessel Disease and Cognitive Impairment in Patients With CADASIL.

Authors:  YuZhi Shi; ShaoWu Li; Wei Li; Chen Zhang; LiYing Guo; YunZhu Pan; XueMei Zhou; XinGao Wang; Songtao Niu; XueYing Yu; HeFei Tang; Bin Chen; ZaiQiang Zhang
Journal:  Front Neurol       Date:  2018-10-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.